ACADIA PHARMACEUTICALS INC (ACAD) Executive Compensation
ACADIA PHARMACEUTICALS INC (ACAD) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ACAD
CIK: 1070494
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerAndrew Kimball
Audit LocationSan Diego, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-09-24 | 2026-09-24 | 8-K | 0001193125-26-401157 | View SEC Doc Filr Page |
| 8-K | 2026-09-11 | 2026-09-11 | 8-K | 0001193125-26-389400 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-08-05 | 4 Filing | 0001899977-26-000008 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-07 | — | SCHEDULE 13G Filing | 0000093751-26-000400 | View SEC Doc Filr Page |
| 144 | 2026-08-05 | — | 144 Filing | 0001967940-26-000042 | View SEC Doc Filr Page |
| 10-Q | 2026-08-05 | 2026-06-30 | 10-Q | 0001193125-26-333243 | View SEC Doc Filr Page |
| 8-K | 2026-08-04 | 2026-08-04 | 8-K | 0001193125-26-332858 | View SEC Doc Filr Page |
| 4 | 2026-07-31 | 2026-07-29 | 4 Filing | 0001861477-26-000005 | View SEC Doc Filr Page |
| 4 | 2026-06-29 | 2026-06-26 | 4 Filing | 0001816160-26-000009 | View SEC Doc Filr Page |
| 144 | 2026-06-26 | — | 144 Filing | 0001967940-26-000036 | View SEC Doc Filr Page |
| S-8 | 2026-06-10 | — | S-8 | 0001193125-26-265809 | View SEC Doc Filr Page |
| 4 | 2026-06-02 | 2026-05-29 | 4 | 0001193125-26-253632 | View SEC Doc Filr Page |
| 4 | 2026-06-01 | 2026-05-29 | 4 Filing | 0001177917-26-000009 | View SEC Doc Filr Page |
| 4 | 2026-06-01 | 2026-05-29 | 4 Filing | 0001865210-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-01 | 2026-05-29 | 4 Filing | 0001365619-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-01 | 2026-05-29 | 4 Filing | 0001604689-26-000009 | View SEC Doc Filr Page |
| 4 | 2026-06-01 | 2026-05-29 | 4 Filing | 0001826361-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-01 | 2026-05-29 | 4 Filing | 0001560782-26-000002 | View SEC Doc Filr Page |
| 8-K | 2026-05-29 | 2026-05-29 | 8-K | 0001193125-26-248242 | View SEC Doc Filr Page |
| 4 | 2026-05-27 | 2026-05-26 | 4 Filing | 0001816160-26-000008 | View SEC Doc Filr Page |
| 144 | 2026-05-26 | — | 144 Filing | 0001950047-26-005016 | View SEC Doc Filr Page |
| 10-Q | 2026-05-07 | 2026-03-31 | 10-Q | 0001193125-26-209731 | View SEC Doc Filr Page |
| 8-K | 2026-05-06 | 2026-05-06 | 8-K | 0001193125-26-209253 | View SEC Doc Filr Page |
| 4 | 2026-05-05 | 2026-05-01 | 4 Filing | 0001816160-26-000007 | View SEC Doc Filr Page |
| 4 | 2026-05-05 | 2026-05-01 | 4 Filing | 0001899977-26-000007 | View SEC Doc Filr Page |